Result Summary for 113055
| Protocol ID: | 113055 |
| Clinical Study ID: | 113055 |
| Official Title: | Evaluation of GSK Biologicals’ Boostrix™ in healthy adults, 10 years after previous booster vaccination |
| Phase: | phase 4 |
| Study Indications or Diseases: |
|
| Generic Name: | Combined Reduced Antigen Content Diphtheria, Tetanus, Acellular Pertussis Vaccine |
| Trade/Product Name: | Boostrix |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
